EPITHELIAL CANCER PATIENTS

Clinical trials for EPITHELIAL CANCER PATIENTS explained in plain language.

Never miss a new study

Get alerted when new EPITHELIAL CANCER PATIENTS trials appear

Sign up with your email to follow new studies for EPITHELIAL CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Engineered immune cells take on Hard-to-Treat cancers

Disease control ENROLLING_BY_INVITATION

This study tests a new treatment called IMC001 for people with advanced epithelial solid tumors (cancers that start in the lining of organs). IMC001 is made from a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The trial has t…

Matched conditions: EPITHELIAL CANCER PATIENTS

Phase: PHASE1, PHASE2 • Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 13:08 UTC

EPITHELIAL CANCER PATIENTS

Get alerted when new EPITHELIAL CANCER PATIENTS trials appear

Engineered immune cells take on Hard-to-Treat cancers